CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Improvement in lifestyle and age related diseases
3.6.1.2. The rise in self-directed consumer
3.6.1.3. Growing awareness regarding general health concerns and advancements in healthcare industry

3.6.2. Restraints

3.6.2.1. Stringent regulatory policies by governing bodies
3.6.2.2. Lack of seamless reclassification of drugs from prescription medicines to over the counter drugs

3.6.3. Opportunities

3.6.3.1. Increasing R&D expenditure and funding from the public & private sector

CHAPTER 4 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. VITAMIN AND DIETARY SUPPLEMENTS (VDS)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. COUGH & COLD PRODUCTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. ANALGESICS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. GASTROINTESTINAL PRODUCTS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. SLEEP AIDS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTIC PRODUCTS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

4.8. WART REMOVERS

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast

4.9. MOUTH CARE PRODUCTS

4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast

4.10. OPHTHALMIC PRODUCTS

4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast

4.11. BOTANICALS

4.11.1. Key market trends
4.11.2. Growth factors and opportunities
4.11.3. Market size and forecast

4.12. ANTACIDS

4.12.1. Key market trends
4.12.2. Growth factors and opportunities
4.12.3. Market size and forecast

4.13. SMOKING CESSATION PRODUCTS

4.13.1. Key market trends
4.13.2. Growth factors and opportunities
4.13.3. Market size and forecast

4.14. FEMININE CARE

4.14.1. Key market trends
4.14.2. Growth factors and opportunities
4.14.3. Market size and forecast

4.15. OTHERS

4.15.1. Key market trends
4.15.2. Growth factors and opportunities
4.15.3. Market size and forecast

CHAPTER 5 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. TABLETS

5.2.1. Market size and forecast

5.3. HARD CAPSULES

5.3.1. Market size and forecast

5.4. POWDERS

5.4.1. Market size and forecast

5.5. OINTMENTS

5.5.1. Market size and forecast

5.6. SOFT CAPSULES

5.6.1. Market size and forecast

5.7. LIQUIDS

5.7.1. Market size and forecast

5.8. OTHERS

5.8.1. Market size and forecast

CHAPTER 6 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS, BY PRODUCT TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. BRANDED

6.2.1. Market size and forecast

6.3. GENERICS

6.3.1. Market size and forecast

CHAPTER 7 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. PHARMACIES

7.2.1. Market size and forecast

7.3. VITAMIN AND HEALTH FOOD STORES

7.3.1. Market size and forecast

7.4. ONLINE PHARMACY

7.4.1. Market size and forecast

7.5. GROCERY STORES

7.5.1. Market size and forecast

7.6. OTHERS

7.6.1. Market size and forecast

CHAPTER 8 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. India market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Argentina market size and forecast
8.5.3.3. Turkey market size and forecast
8.5.3.4. Saudi Arabia market size and forecast
8.5.3.5. South Africa market size and forecast
8.5.3.6. Rest of LAMEA market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. PFIZER INC.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. NOVARTIS INTERNATIONAL AG

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments

9.3. ROCHE HOLDING AG

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments

9.4. MERCK & CO., INC.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments

9.5. SANOFI S.A

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. JOHNSON & JOHNSON

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. GILEAD SCIENCES

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments

9.8. GLAXOSMITHKLINE PLC

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments

9.9. BAYER HEALTHCARE AG

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. ASTRAZENECA PLC

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments